Abstract：
OBJECTIVE: Given the prevalence of heart failure (HF) and the interdisciplinary nature of device therapy, it is paramount that cardiologists not only understand the current landscape of goal-directed medical therapy, but also the ongoing efforts in device development. Thus, we aim to provide a practical overview of the broad approaches being utilized in the burgeoning field of device-based therapies for heart failure.
RESULTS: Currently, a diverse array of devices for HF treatment is being developed and tested, each targeting distinct aspects of HF pathophysiology. These innovative solutions encompass a wide spectrum, ranging from devices enabling remote monitoring of HF associated physiological parameters, to those focused on creating interatrial shunts and effecting structural modifications of the left ventricle, as well as to those designed to modulate the autonomic nervous system and diaphragm. Notably, a subset of these emerging devices is directed towards treating patients with heart failure with preserved ejection fraction, a population that has traditionally not been served by device-based therapies.
CONCLUSIONS: In recent decades, there has been a remarkable surge in the development and utilization of device-based treatments for managing HF. It is important for physicians to be familiar with these devices, their mechanisms of action, and their applications.
RESULTS: Currently, a diverse array of devices for HF treatment is being developed and tested, each targeting distinct aspects of HF pathophysiology. These innovative solutions encompass a wide spectrum, ranging from devices enabling remote monitoring of HF associated physiological parameters, to those focused on creating interatrial shunts and effecting structural modifications of the left ventricle, as well as to those designed to modulate the autonomic nervous system and diaphragm. Notably, a subset of these emerging devices is directed towards treating patients with heart failure with preserved ejection fraction, a population that has traditionally not been served by device-based therapies.
CONCLUSIONS: In recent decades, there has been a remarkable surge in the development and utilization of device-based treatments for managing HF. It is important for physicians to be familiar with these devices, their mechanisms of action, and their applications.
摘要：
目的：鉴于心力衰竭（HF）的患病率和器械治疗的跨学科性质，最重要的是，心脏病学家不仅要了解目标导向医学治疗的现状，还有设备开发方面的持续努力。因此，我们的目标是对新兴的基于设备的心力衰竭治疗领域中使用的广泛方法进行实用概述。
结果：目前，正在开发和测试各种用于HF治疗的设备，每个针对HF病理生理学的不同方面。这些创新的解决方案涵盖了广泛的领域，包括能够远程监测HF相关生理参数的设备，对于那些专注于创建心房分流并影响左心室结构改变的人，以及那些旨在调节自主神经系统和隔膜的人。值得注意的是,这些新兴设备的一个子集是针对治疗心力衰竭患者的保留射血分数，传统上没有使用基于设备的疗法的人群。
结论：近几十年来，在开发和利用基于设备的治疗来管理HF方面出现了显着的激增。对于医生来说，熟悉这些设备很重要，他们的行动机制，及其应用。
结果：目前，正在开发和测试各种用于HF治疗的设备，每个针对HF病理生理学的不同方面。这些创新的解决方案涵盖了广泛的领域，包括能够远程监测HF相关生理参数的设备，对于那些专注于创建心房分流并影响左心室结构改变的人，以及那些旨在调节自主神经系统和隔膜的人。值得注意的是,这些新兴设备的一个子集是针对治疗心力衰竭患者的保留射血分数，传统上没有使用基于设备的疗法的人群。
结论：近几十年来，在开发和利用基于设备的治疗来管理HF方面出现了显着的激增。对于医生来说，熟悉这些设备很重要，他们的行动机制，及其应用。
